Open tender · Germany · Cn Standard

Abschluss eines nicht exklusiven Rabattvertrages nach § 130a Abs. 8 SGB V für die im Rahmen des Sprechstundenbedarfs in Niedersachsen verordnungs- und abgabefähigen Arzneimittel mit dem Wirkstoff Enoxaparin (ATC-Code: B01AB05).

AOK Niedersachsen. Die Gesundheitskasse.

The work

Non-exclusive pharmaceutical rebate contracts for Enoxaparin in Lower Saxony under § 130a Abs. 8 SGB V

  • Must be a pharmaceutical entrepreneur under § 4 Abs. 18 AMG
  • Contracts must be registered in Lauer-Taxe®
  • Submission deadline for initial contracts: 30.10.2025

Key facts

Contract period
24 months maximum, starting from 01.12.2025
Evaluation
Not applicable as this is not a public procurement tender

What it takes to qualify

Worth a closer look

  • The tender is not a public procurement in the sense of Directive 2014/24/EU
  • Submission mode and envelope structure are not specified
  • No explicit mention of DSC or physical copies

Experience

  • At least 1 similar work — Prior experience with pharmaceutical rebate contracts is implied by the requirement to be a pharmaceutical entrepreneur
  • Experience as a pharmaceutical entrepreneur (pharmazeutischer Unternehmer) under § 4 Abs. 18 AMG

Certifications and registrations

Lauer-Taxe® registrationRequired for contract registration
GST registration (optional)Not stated in the provided text

Policy conditions

No reservation, preference or local-content restriction.

Documents to submit

  1. Contract documents and conditionsTo be requested from ARGE-SSB and submitted